man with virtual reality goggles on Researchers found data that showed young patients in the early phase of schizophrenia would benefit by the Virtual Reality Functional Capacity Assessment Tool, as a ...

Currently, the primary efficacy measures for antidepressant clinical trials predominantly assess changes in mood symptoms in patients with major depressive disorder (MDD). When considering treatment ...

Israeli biotechnology firm ElMindA – developers of the world’s first FDA-approved neural functional assessment tool to visualize serious brain trauma and illnesses – has been named one of the 49 most ...

Researchers developed a standardized tool to assess the functional impact of tardive dyskinesia on patients. A standardized scale to assess the severity of symptoms in patients with tardive dyskinesia ...